In the BioHarmony Drug Report Database
Aprotinin
Trasylol (aprotinin) is an unknown pharmaceutical. Aprotinin was first approved as Trasylol on 1993-12-29. It is used to treat hemorrhage in the USA. The pharmaceutical is active against plasminogen.
Trade Name
|
Trasylol |
|---|---|
Common Name
|
aprotinin |
ChEMBL ID
|
CHEMBL1201619 |
Indication
|
hemorrhage |
Drug Class
|
Image (chem structure or protein)
